Vaccines Flashcards
(21 cards)
Vaccine
Substance used to stimulate antibody production and provide immunity against one or more diseases w/o inducing disease
1. Barriers
A. Rumors
B. Myths
Goals of disease management
- Disease control (disease currently present)
- Disease prevention
- Disease elimination - in given location w/ cont intervention
- Disease eradication - globally w/o intervention
- Disease extinction - not present in nature or lab
Threshold population
Susceptible pop large enough for pathogen to become est. and persist
- Related to basic reproduction # of pathogen
- If susceptible falls below pathogen not transmitted
Herd immunity
Unvaccinated protected by vaccinated
- R0 = avg. # secondary cases from one primary case in susceptible pop
- Inc # resistant hosts
- % of pop that need to be immune retaliated to R0 = 1-1/R0
Passive immunity
1. Purified antibodies A. Antitoxins/anti venom B. Tumors immunotherapy C. Part of rabies tx 2. Maternal protection A. IgG across placenta B. Breast milk IgA
Active immunity
- Dev naturally after infection or vaccination
- Slower immunity dev
- Long-lasting immunity
- Possible immunological memory
Live attenuated
- Infectious
- Loss of virulence factors
- Risks
A. Reversion to virulent - rare
B. Recombination to virulent - rare
C. Disease in immunocompromised pts
D. Temp sensitivity
E. Contaminating viruses
F. Abortigenic/teratogenic
Live attenuated vaccine examples
- MMR
- Influenza (mist)
- Varicella
- Rotavirus
- Yelllow fever
- Small pox
- BCG
- Oral polio
Inactivated/killed vaccines
- Can’t replicate
- Inactivated:
A. Chemically- Formaldehyde
- Thiomersal
- Ethylene oxide
- Beta-proiolactone
- Ethylenimine
B. Temp
C. Irradiation - not dead, just inactivated
- Cons
A. Less effective than live
B. DIVA prob = distinguishing infected from vaccinated - Toxoidsi
Toxoids
Inactivated pathogenic toxins that induce host antitoxins
- Tetanus toxoid
- Diptheria toxoid
Genetically engineered vaccines
1. Recombinant DNA A. 2+ species DNA combined B. Gene segments/fragments C. Plasmids D. Naked DNA E. HIV experimental vaccine 2. Virus-like particles A. Used in HPV vaccine
Alum
Commonly used adjuvant
- Promotes aggregates for phagocytosis
- Th2 skew
- Boosters necessary
- Allergies and granulomas possible
- Keeps vaccine in one place
Adverse events to vaccines
- Hypersensitivity
- Injection site problems
- Inadequate inactivation
- Recombination
- Disease in immunocompromised pts
- Dec effectiveness
A. Temp variations
Dengue fever vaccine
Dengvaxia: first promising dengue vaccine
1. Widespread globally early 2016
2. Live recombinant tetravalent vaccine
A. 3 doses, 6mo apart
3. 80% effective
4. Countries funded vaccines
5. If vaccination is 1st exposure, next exposure more severe than never vaccinated
A. Maybe antibody enhances pathogenesis
Ideal vaccines
- Cheap
- High quality
- Stable at variable temps
- Long shelf life w/o preservatives
- Induce correct, protective response
- Multivalent
- Induce immune memory
- No ADE
Vaccine 10 commandments
- Not every person needs every vaccine
- Core vaccine = every person should get it
- Give to as many herd members as possible
- Young -> special considerations
- Immunize as infrequently as possible - avoid infection risk
- Not for pregnant women unless specifically recommended
- Not for ill/immunocompromised unless specifically recommended
- Decide w/ pt which/when to give
- Read and understand data sheet
- Keep records of vaccinations and ADEs
Vaccination schedules
- Hep B only one given at birth
2. Those given in susceptible window usually boosted
Vaccines given under 1 y/o
- Hep B
- Rotavirus
- DTaP
- HiB
- Pneumococcal
- Polio
- Flu
Vaccines given at 1 y/o
- MMR
- Chickenpox
- Hep A
Vaccines given over 7 y/o
- TDaP
- HPV
- Meningococcal
Type III hypersensitivity
- Over-active IgG
- Immune complexes
- Arthus rxn:
A. Local vasculitis and necrosis
B. Extensive and painful swelling